AI assistant
EXOZYMES INC. — Director's Dealing 2024
Nov 19, 2024
34055_dirs_2024-11-18_65a863be-5474-4479-b406-e250f0ff0ed3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Invizyne Technologies Inc (IZTC)
CIK: 0002010788
Period of Report: 2024-11-08
Reporting Person: Heltzen Michael (Chief Executive Officer)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options for Common Stock | $3.31 | 2031-08-31 | Common Stock (155818) | Direct | |
| Stock Options for Common Stock | $3.31 | 2032-01-31 | Common Stock (155818) | Direct | |
| Stock Options for Common Stock | $8.00 | 2031-03-31 | Common Stock (22097) | Direct |
Footnotes
F1: The first 31,164 shares vest on January 31,2025, then at the rate of 7,791 shares per quarter, and the balance of shares shall vest on the five-year anniversary of the Date of Grant.
F2: The first 31,164 shares vest on January 31,2025, then at the rate of 7,791 shares per quarter, and the balance of shares shall vest on the five-year anniversary of the Date of Grant.
F3: The first 4,416 shares vest on April 12, 2025, then at the rate of 1,104 shares per quarter, commencing on July 12, 2025, and the balance of shares shall vest on the five-year anniversary of the Date of Grant.